The store will not work correctly when cookies are disabled.
1-Allyl-5-(3-thiophen-2-yl-allylidene)-2-thioxo-dihydropyrimidine-4,6-dione
ID: ALA4175037
PubChem CID: 145951079
Max Phase: Preclinical
Molecular Formula: C14H12N2O2S2
Molecular Weight: 304.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CCN1C(=O)/C(=C\C=C\c2cccs2)C(=O)NC1=S
Standard InChI: InChI=1S/C14H12N2O2S2/c1-2-8-16-13(18)11(12(17)15-14(16)19)7-3-5-10-6-4-9-20-10/h2-7,9H,1,8H2,(H,15,17,19)/b5-3+,11-7-
Standard InChI Key: DNWMSHFEJKMXOO-PGACXJNKSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
7.5639 -7.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2784 -6.9213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9928 -7.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9928 -8.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2784 -8.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5639 -8.1588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7073 -6.9213 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2784 -9.3963 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8494 -6.9213 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.7073 -8.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7073 -9.3963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4218 -9.8088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4218 -10.6338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0892 -11.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8343 -11.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0093 -11.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7543 -11.1187 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.8494 -8.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1350 -8.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4205 -8.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
13 17 1 0
12 13 1 0
4 10 2 0
18 19 1 0
19 20 2 0
6 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.40 | Molecular Weight (Monoisotopic): 304.0340 | AlogP: 2.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.69 | CX Basic pKa: ┄ | CX LogP: 3.07 | CX LogD: 2.89 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.40 | Np Likeness Score: -1.84 |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |